# Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/early-is-superior-to-deferred-preemptive-lamivudine-therapy-for-hepatitis-b/

## Facts

| Field | Value |
| --- | --- |
| Author Names | George Lau,Harry Yiu,Dyt Fong,Hoi-Ching Cheng,Wing‐Yan Au,Lydia S.F Lai,M M H Cheung,Haiying Zhang,A K W Lie,Roger K.C. Ngan,Raymond Liang |
| Citations | 460 |
| DOI | 10.1053/j.gastro.2003.09.026 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.gastrojournal.org/article/S001650850301518X/pdf |
| OpenAlex ID | https://openalex.org/W2085997970 |
| PMID | 14724827 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Dyt Fong](https://scholariq.org/researchers/dyt-fong/)

## Paper journal

- [Gastroenterology](https://scholariq.org/journals/gastroenterology/)

## Paper primary topic

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)

## Paper topics

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.